Integrated BioTherapeutics

Integrated BioTherapeutics Overview

Founded 2005
Founded
Status Private
Employees 30
Employees
Latest Deal Type Later Stage VC
Latest Deal Amount $3.9M
Latest Deal Amount
Investors 5

Integrated BioTherapeutics General Information

Description

Developer of toxin-based vaccines intended to help control infectious diseases. The company's toxin-based vaccines can protect against all ebolaviruses, a common cause of both hospital-acquired and community-acquired infections and bacterial sepsis and also discovery novel vaccines and therapeutics, enabling healthcare providers to treat emerging infectious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 4 Research Court
  • Suite 300
  • Rockville, MD 20850
  • United States
+1 (877) 000-0000

Integrated BioTherapeutics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Integrated BioTherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 06-Jan-2020 $3.9M 00.000 Completed Product Development
10. Grant 01-Jan-2018 00000 0000 Completed Product Development
9. Grant 01-Aug-2017 00.00 0000 Completed Product Development
8. Grant 01-Jan-2016 00000 0000 Completed Product Development
7. Grant 01-Jan-2015 00000 0000 Completed Product Development
6. Grant 01-Jan-2014 00000 0000 Completed Product Development
5. Grant 01-Jan-2013 00000 0000 Completed Product Development
4. Grant 22-Aug-2012 00000 0000 Completed Product Development
3. Debt - General 29-Jun-2011 $75K Completed Product Development
2. Accelerator/Incubator 12-Aug-2010 $75K Completed Product Development

Integrated BioTherapeutics Executive Team (2)

Name Title Board Seat Contact Info
M. Javad Aman Ph.D Co-Founder, Chief Scientific Officer and President

1 Former Executive

Integrated BioTherapeutics Investors (5)

To view Integrated BioTherapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0
National Institute Of Allergy and Infectious Diseases Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Maryland Industrial Partnerships Accelerator/Incubator 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial